INTRODUCTION
============

Skin dryness, xerosis, is a common problem not only in the elderly but also in various skin disorders. Xerosis can be caused by numerous factors such as dysregulation of epidermal differentiation and lipid content, the use of drugs such as diuretics and overuse of heaters or air conditioners[@B1]. Skin xerosis causes pruritus, leading to skin inflammation, infections, and even wrinkles. Therefore, research to find active molecules to enhance skin hydration by normalizing epidermal differentiation and barrier function is of great interest.

The epidermis is the outermost cellular layer of skin, which provides functions such as the protection of the body from environmental challenges, prevention of water loss, and thermoregulation. The barrier function of the epidermis involves the expression of numerous tissue-specific genes, most of which are specifically expressed in late keratinocyte differentiation. In order to establish proper skin barrier, keratinocytes undergo a complex epidermal differentiation process, which is the transition from basal keratinocytes to corneocytes[@B2]. The dysregulation of keratinocyte differentiation results in skin barrier disruption and causes skin dryness and skin diseases such as psoriasis and atopic dermatitis[@B3].

Recently, there have been many studies investigating the genetic variants in skin phenotypes using a genome-wide association study (GWAS), but most GWAS on skin phenotypes have only focused on the pigmentation traits or tanning abilities between races[@B4][@B5][@B6]; there have been no previous reports of GWAS on skin hydration. In the present study, we performed a GWAS to determine the genetic factors influencing skin hydration in Korean females, and we define the functional roles of genes containing selected single nucleotide polymorphisms (SNPs) in human epidermal keratinocytes.

MATERIALS AND METHODS
=====================

Population and phenotype
------------------------

The local Ethics Committee and the Institutional Review Board (IRB) at Chungnam University Hospital (IRB no. 2012-08-019) approved this study, and informed consent was obtained from all participants regarding the study\'s scientific aims as well as the use of saliva, DNA and clinical records for all stages. A total of 100 healthy volunteers were enrolled for the study (Korean females, aged 30\~50 years) living in the same city. Skin capacitance, a widely accepted parameter of stratum corneum hydration, was measured using a Corneometer® CM 825 (Courage & Khazaka Electronic, Cologne, Germany) on the anterior aspect of left cheek. All measurement were done after sit and rest for 15 min in constant temperature and humidity conditions (22℃±2℃, 50%±5%). The tested volunteers were divided into groups according to the corneometer (CM) value: i) CM value ≤40 (dry skin), ii) 40\< CM value \<60, and iii) CM value ≥60 (hydrated skin) ([Table 1](#T1){ref-type="table"}).

Genotyping, quality control and GWAS
------------------------------------

The Oragene (DNA Genotek, Kanata, ON, Canada) saliva kit was used to collect highly purified DNA from the saliva of volunteers. In the GWAS, 100 subjects were genotyped by using the Axio™ Genome-Wide ASI 1 Array Plate (Affymetrix, Santa Clara, CA, USA) comprised of 598,100 SNPs. The PLINK (ver. 1.06) and R statistical programs (<http://www.r-project.org/>) (ver. 2.10.1) were used for quality control procedures. SNPs were filtered if the following criteria were satisfied: i) a call rate of \<95% (n=15,314), ii) a minor allele frequency of \<1% (n=76,211), and iii) a significant deviation from Hardy-Weinberg equilibrium of ≤1×10^−3^ (n=489). After quality control, 506,945 SNPs (84.7% of 598,375) were remaining for association analysis. Association analysis was performed using 506,945 common SNPs that satisfied the quality control criteria using quantitative trait analysis (Wald test).

Immunohistochemical staining
----------------------------

Skin samples were obtained from 5 patients from skin lesions in trunk of patients with psoriasis, atopic dermatitis or ichthyosis. The tissues were fixed in 10% formalin for 24 h and embedded in paraffin. Sections of skin specimens were dewaxed, rehydrated, and then washed three times with phosphate-buffered saline. After treatment with proteinase K (1 mg/ml) for 5 min at 37℃, sections were treated with H~2~O~2~ for 10 min at room temperature, placed in a blocking-solution (Dako, Carpinteria, CA, USA) for 20 min, followed by reaction with the appropriate primary antibodies. Sections were incubated sequentially with peroxidase-conjugated secondary antibodies (Upstate, Lake-Placid, NY, USA) and visualized using a Chemmate Envision Detection Kit (Dako). Following antibodies were used in this study: single stranded DNA binding protein 3 (SSBP3) (Abcam, Cambridge, MA, USA). The intensity of SSBP3 in epidermis was analyzed using ImageJ analysis program (<http://imagej.nih.gov/ij/docs/index.html>).

Cell culture
------------

Human skin tissues were obtained under the written informed consent of donors, in accordance with the ethical committee approval process of the Institutional Review Board of Chungnam National University Hospital (IRB no. 2016-07-009). Human skin tissues were obtained from trunk skin that was the remnant of benign skin tumor surgery. Primary keratinocytes were cultured according to the method previously described[@B7]. Human epidermal keratinocytes were cultured in keratinocyte-serum free medium supplemented with bovine pituitary extract and recombinant human epidermal growth factor (Life Technologies Corporation, Grand Island, NY, USA).

Production of recombinant adenovirus
------------------------------------

Total RNA was isolated from cultured skin epithelial cells using Easy-Blue RNA extraction kit (Intron, Daejeon, Korea). Two µg of total RNA was reverse transcribed with moloney-murine leukaemia virus (M-MLV) reverse transcriptase (RTase) (ELPIS Biotech, Daejeon, Korea). Aliquot of RT mixture was subjected to polymerase chain reaction (PCR) cycles with primer set for SSBP3 5′-GGCAGATCTA TGTTTGCCAAAGGCAAAGGC-3′ and 5′-TTTGTCGACT CACACACTCATCGTCATGC-3′. SSBP3 cDNA was subcloned into pENTR/CMV-Flag vector that has attL sites for site-specific recombination with a Gateway destination vector (Invitrogen, Carlsbad, CA, USA). The replication-incompetent adenoviruses were created using Virapower adenovirus expression system (Invitrogen) according to the method previously described[@B8]. Briefly, site-specific recombination between entry vector and adenoviral destination vector was achieved by LR clonase (Invitrogen). The resulting adenoviral expression vector was then transfected into 293A cells using Lipofectamine 2000 (Invitrogen). Cells were grown until 80% cytopathic effect was seen, then harvested for preparation of recombinant adenovirus. For microRNA (miR) specific for SSBP3, target sequences were designed using Invitrogen\'s RNAi Designer (<http://rnaidesigner.lifetechnologies.com/rnaiexpress>). The miR sequences were as follows: top strand 5′-TGCTGTTCAGAACCAGACTACAAGGTGTTTTGGCCA CTGACTGACACCTTGTACTGGTTCTGAA-3′ and bottom strand 5′-CCTGTTCAGAACCAGTACAAGGTGTCAGTCA GTGGCCAAAACACCTTGTAGTCTGGTTCTGAAC-3′. The double-stranded DNA oligonucleotides were synthesized and cloned into the parental vector pcDNA6.2-GW/EmGFP-miR (Invitrogen). The expression cassette for miR was moved into the pENTR/CMV vector and adenovirus was made as previously reported[@B8].

Calcium-induced differentiation model
-------------------------------------

To induce keratinocyte differentiation *in vitro*, we adopted a well-established calcium-induced differentiation model. After adenoviral transduction, cells were replenished with keratinocyte-serum free medium and then cultured for a further 3 days with or without calcium (1.8 mM).

Western blot analysis
---------------------

Cells were lysed in Proprep solution (Intron). Total protein was measured using a BCA protein assay kit (Pierce Biotechnology, Rockford, IL, USA). Samples were run on SDS-polyacrylamide gels, transferred to nitrocellulose membranes and incubated with appropriate antibodies. Blots were then incubated with peroxidase-conjugated secondary antibodies, visualized by enhanced chemiluminescence (Intron). For determination of secreted proteins, cell culture medium was concentrated using a Protein concentration kit (Elpis Biotech). The following primary antibodies were used in this study: SSBP3 (Abcam); actin (Sigma-Aldrich, St. Louis, MO, USA).

Reverse transcription-PCR (RT-PCR)
----------------------------------

Total RNAs were isolated using Easy-Blue RNA extraction kit. Two µg of total RNAs were reverse transcribed with M-MLV RTase (Elpis Biotech). Aliquots of RT mixture were amplified using SYBR Green real-time PCR master mix (Elpis Biotech). The following primers sequences were used: SSBP3, 5′-ATGCTTGGGACTGGATGGAA and 5′-C AAAGACCAGCTACAGGGGA; Involucrin, CCATCAGGA GCAAATGAAACAG and GCTCGACAGGCACCTTCTG; Loricrin, AATAGATCCCCCAGGGTACCA and CGGTGCC CCTGGAAAAC; K1, GGCTATGAC CCTGCTTTGTTCT and TCATGTGGGTGGTGGTCACT; GAPDH, 5′-TGCAC CACCAACTGCTTAGC and 5′-GGCATGGACTGTGGTCA TGAG.

Luciferase assay
----------------

Cells were grown at 70% confluency in a 24 well culture plate and co-transduced with reporter adenovirus and SSBP3 expressing adenovirus. After adenoviral transduction, cells were replenished with fresh medium. Cells were further incubated for 48 h, and then cellular extracts were prepared using cell lysis buffer. Luciferase activities were determined using Luciferase assay system (Promega, Madison, WI, USA), according to the recommended protocol.

Statistical analysis for *in vitro* study
-----------------------------------------

RT-PCR and luciferase assay were evaluated statistically using one-way ANOVA using IBM SPSS Statistics software (ver. 22.0; IBM Co., Armonk, NY, USA). Statistical significance was set at *p*\<0.01.

RESULTS
=======

Association between SNPs and hydration phenotypes
-------------------------------------------------

To identify significant loci associated with skin hydration, we genotyped 598,100 SNPs in 100 individuals using Axiom™ Genome-Wide ASI 1 Array Plate. The samples consisted of individuals with CM values. After quality control, we analyzed the association of 501,262 common markers using quantitative trait analysis (Wald test). Among several SNPs identified in GWAS, we focused on SSBP3 which is known to be associated with DNA replication, DNA damage repair and cell differentiation ([Table 2](#T2){ref-type="table"}).

Expression of SSBP3 in epidermal keratinocytes
----------------------------------------------

First, we evaluated the endogenous expression of SSBP3 in epidermal cells, including normal human epidermal keratinocytes (NHEKs) and HaCaT cells, and found that SSBP3 was expressed in both skin cell lines ([Fig. 1A](#F1){ref-type="fig"}). Next, we confirmed the expression of SSBP3 in normal human skin using immunohistochemical analysis. We noted that SSBP3 is expressed in all layers of epidermis. However, the intensity of SSBP3 was low in proliferative cells in the basal cell layer of epidermis but strongest in the spinous layers which begin to express proteins required for cornification ([Fig. 1B](#F1){ref-type="fig"}).

Overexpression of SSBP3 promotes keratinocyte differentiation
-------------------------------------------------------------

Since the expression of SSBP3 was increased during the keratinocyte differentiation process, we investigated the putative role of SSBP3 in epidermal differentiation. To examine SSBP3 during keratinocyte differentiation, we adopted a well-established calcium-induced differentiation model. As expected, SSBP3 was upregulated in a time-dependent manner from day 3 after calcium treatment and decreased at day 7, which was consistent with the result of immunohistochemical analysis showing that SSBP3 was most prominent in the spinous layer of the epidermis ([Fig. 2A](#F2){ref-type="fig"}). We then constructed a recombinant adenovirus expressing SSBP3 and transduced cultured human epidermal keratinocytes ([Fig. 2B](#F2){ref-type="fig"}). Overexpression of SSBP3 led to a significant increase in mRNA levels of epidermal differentiation related markers such as K1, involucrin, and loricrin ([Fig. 2C](#F2){ref-type="fig"}). Next, we transduced keratinocytes with each involucrin-luc and loricrin-luc reporter adenoviruses, in which about 3.7 kb of the involucrin promoter fragment and 2.0 kb of the loricrin promoter fragment were fused to the luciferase gene. Overexpression of SSBP3 significantly increased the involucrin and loricrin luciferase activities compared to the Ad/LacZ control ([Fig. 2D](#F2){ref-type="fig"}). And we also confirmed that overexpression of SSBP3 increased the expression of involucrin and loricrin in protein levels ([Fig. 2E](#F2){ref-type="fig"}).

Knockdown of SSBP3 inhibits keratinocyte differentiation
--------------------------------------------------------

We further confirmed the role of SSBP3 on keratinocyte differentiation by knockdown experiment. To this end, we transduced keratinocytes with recombinant adenovirus expressing miR specific for SSBP3 ([Fig. 3A](#F3){ref-type="fig"}). As shown in [Fig. 3B](#F3){ref-type="fig"}, mRNA levels of K1, involucrin, and loricrin were significantly decreased by SSBP3 knockdown even with the calcium treatment. Consistent with the quantitative PCR (qPCR) analysis results, SSBP3 downregulation led to decreased luciferase activities of loricrin and involucrin compared to the control groups ([Fig. 3C](#F3){ref-type="fig"}). The results suggest that knockdown of SSBP3 decreased differentiation of keratinocytes through decreased transcriptional activity via specific DNA binding to the promoter regions of epidermal differentiation-related genes. Knockdown of SSBP3 also inhibited the expression of involucrin and loricrin in protein levels ([Fig. 3D](#F3){ref-type="fig"}).

Expression of SSBP3 in skin diseases related to keratinocyte differentiation
----------------------------------------------------------------------------

Since SSBP3 can regulate keratinocyte differentiation *in vitro*, we hypothesized that SSBP3 expression may have a correlation to skin disease relating to keratinocyte differentiation. We examined SSBP3 expression in ichthyosis, atopic dermatitis and psoriasis, which are skin disorders showing abnormal keratinocyte differentiation and decreased moisturization due to a defect in the skin barrier. As expected, decreased expression of SSBP3 was found in psoriasis, a multisystemic disease characterized by hyperproliferation and altered differentiation of the epidermis ([Fig. 4A](#F4){ref-type="fig"}). SSBP3 was also decreased in the spinous layer in ichthyosis, a disease caused by a loss-of-function mutation that results in keratinocyte disruption ([Fig. 4B](#F4){ref-type="fig"}). Finally, diffuse nuclear staining of SSBP3 was observed in the basal and lower spinous layers of epidermis in atopic dermatitis, an inflammatory skin disease showing defects in keratinocytes differentiation and the skin barrier; however, the intensity of staining was decreased in the upper spinous and granular layers ([Fig. 4C](#F4){ref-type="fig"}).

DISCUSSION
==========

Epidermis, the outermost part of the skin composed mainly of keratinocytes, is a self-renewing, multilayered, stratified, and keratinized squamous epithelium. It provides a physical barrier from dehydration and various environmental stresses[@B2]. To maintain the protective barrier continuously, keratinocytes should be well balanced in proliferation, differentiation and apoptosis. Incomplete barrier acquisition and dysregulation of keratinocyte differentiation manifest as dehydration, electrolyte imbalance, poor thermoregulation and predisposition to infection[@B9][@B10]. In addition, abnormal epidermal keratinocyte differentiation causes barrier dysfunction and skin disorders such as psoriasis and atopic dermatitis.

Decreased hydration is a problem not only in people with skin disorders, but also in healthy populations, and the frequency of dry skin increases with aging. In dry skin, there are significant changes in the epidermal expression of basal and differentiation-related keratins and premature expression of involucrin, which is related to terminal differentiation, meaning that skin hydration is closely related to epidermal differentiation[@B11]. As adequate skin hydration is critical for maintaining healthy skin, there is significant ongoing research into finding active target molecules to improve skin hydration.

Recent developments in the study of molecular genetics have added to our understanding of how genetic differences account for variations among individuals. GWAS, a method used to identify genetic variations in different individuals, focuses on associations between SNPs and phenotypes. Numerous conventional genetic studies have identified particular target regions and susceptible loci for diseases and traits. Lately, genetic studies have been conducted to find the loci associated with skin phenotypes such as pigmentation[@B12][@B13][@B14]. Yet, there has been no published genetic study identifying loci associated with phenotypes of skin hydration. In this report, we present GWAS analyses that demonstrate that *SSBP3* is associated with an individual\'s hydration phenotype. In addition, we present a functional study of *SSBP3* confirming the biological relevance of this gene in skin hydration. We first selected all the genes that show the relationship with cell differentiation signaling pathway but not yet been investigated in epidermal differentiation. The lowest *p*-value of the gene SSBP3 is 7.15×10^−3^ in the current study, which does not reach GWAS significant level but several SNPs were identified in the intronic region of *SSBP3* and *SSBP2*. Also, previous literatures elucidated the functional role of *SSBP3* in cell differentiation and cell cycle; however, no studies have reported a relationship between *SSBP3* and epidermal keratinocytes. So, we presented other evidences to support the GWAS through further functional studies that *SSBP3* has susceptibility of epidermal differentiation using *in vitro* cell experiments.

SSBPs are part of the oligonucleotide/oligosaccharide-binding fold domain family and function in DNA replication at the restart of stalled replication forks, DNA damage repair, cell cycle-checkpoint activation, and telomere maintenance[@B15]. The human *SSBP3* gene was first identified as a member of an evolutionarily conserved and ubiquitously expressed gene family with possible involvement in cancer[@B16]. *SSBP3* has also been reported to have important roles in neuronal morphology and is highly expressed in skeletal muscle, heart, brain, kidney, and hematopoietic tissues. Previous studies have shown that SSBPs modulate axis formation in *Xenopus*, wing development in *Drosophila*, and head morphogenesis in mice[@B17][@B18][@B19][@B20]. SSBP3 has been found to regulate DNA replication, recombination, and repair by binding to DNA, and overexpression of SSBP3 induces differentiation of mouse embryonic stem cells into trophoblast-like cells, indicating the possibility that SSBP3 might act as a positive regulator in epidermal differentiation[@B21][@B22]. In this study, all the genetic variants were detected in the intronic region of *SSBP3*. In the past, introns are often considered as useless part of the gene that is removed to create an mRNA. However, recent papers propose the effect of introns on expression of genes. The mechanism of how introns regulate gene expression is not entirely clear, but many studies show introns can affect gene expression at many different levels, including transcription, polyadenylation, mRNA export, translational efficiency, and the rate of mRNA decay[@B23][@B24].

In conclusion, we demonstrated a role for SSBP3 in keratinocyte differentiation using an adenoviral gene delivery system. Specifically, SSBP3 overexpression in keratinocytes led to a significant increase in epidermal differentiation-related gene expression and activity. Conversely, knockdown of SSBP3 decreased epidermal differentiation-related gene expression and activity. In addition, psoriasis and atopic dermatitis, which are the skin disorders with altered epidermal differentiation and skin dehydration, showed decreased expression of SSBP3[@B25]. These results suggest that SSBP3 may be linked to an individual\'s hydration skin phenotype by positively regulating keratinocyte differentiation. Although the number of enrolled subjects was relatively small, and the *p*-value of the SNP was not small enough to confirm the relationship between the SNP and skin hydration, we believe these results may contribute to a better understanding of skin hydration through better understanding of the factors regulating epidermal differentiation and provide new insights into the development of possible treatment targets for abnormal differentiation-related skin disorders via modulation of SSBP3. A larger sample size would be useful in detecting additional SNPs associated with skin hydration in future studies.
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![Expression of SSBP3 in epidermal keratinocytes and epidermis. (A) Cellular extracts were prepared from cultured normal human epidermal keratinocytes (NHEKs) and HaCaT cells. The endogenous protein expression of SSBP3 was detected via western blot analysis. (B) Paraffin-embedded normal skin tissue was immunohistochemically stained with anti-SSBP3. Immunohistochemical staining shows nuclear SSBP3 staining in all epidermal layers and increased SSBP3 positive staining in the spinous layer (hematoxylin and DAB, ×200; scale bar=50 µm).](ad-30-432-g001){#F1}

![Effect of SSBP3 overexpression on keratinocyte differentiation. (A) Keratinocytes were treated with 1.8 mM CaCl~2~ for indicated times. SSBP3 protein levels were detected via western blot analysis. Actin was used as a loading control. (B) Keratinocytes were transduced with recombinant adenoviruses expressing SSBP3 or LacZ control for 12 h. Cells were replenished with fresh medium and then cultured for 3 days. mRNA level of *SSBP3* was determined by quantitative polymerase chain reaction (qPCR). (C) After overexpression of SSBP3 in keratinocytes, cells were further treated with 1.8 mM CaCl~2~ for 3 days. The mRNA levels of epidermal differentiation-related markers involucrin, loricrin, and cytokeratin 1 (K1) were measured using qPCR. (D) The effect of SSBP3 overexpression on loricrin and involucrin promoter activity. The involucrin or loricrin promoter-luciferase reporter adenoviruses were co-transduced with adenoviruses expressing SSBP3 or LacZ for 12 h. Cells were replenished with fresh medium and treated with 1.8 mM CaCl~2~. Cells were further cultured for 3 days and assayed for luciferase activity. (E) After overexpression of SSBP3 in keratinocytes, cells were further treated with 1.8 mM CaCl~2~ for 3 days. The protein expression of involucrin and loricrin were examined by western blot analysis. Actin was used as a loading control. Values are presented as mean±standard deviation of triplicate measurements (^\*^*p*\<0.01).](ad-30-432-g002){#F2}

![Effect of SSBP3 knockdown on keratinocyte differentiation. (A) Keratinocytes were transduced with adenoviruses expressing microRNA (miR)-SSBP3 or scrambled control (miR-scr) for 12 h. Cells were replenished with fresh medium and then cultured for 3 days. The SSBP3 protein level was measured via western blot analysis. Actin was used as the loading control. (B) After knockdown of SSBP3 in keratinocytes, cells were further treated with 1.8 mM CaCl~2~ for 3 days. The mRNA levels of epidermal differentiation-related markers involucrin, loricrin, and cytokeratin 1 (K1) were measured using quantitative polymerase chain reaction. (C) The effect of SSBP3 knockdown on involucrin and loricrin promoter activity. The involucrin or loricrin promoter-luciferase reporter adenoviruses were co-transduced with adenoviruses expressing miR-SSBP3 or miR-scr for 12 h. Cells were replenished with fresh medium and treated with 1.8 mM CaCl~2~. Cells were further cultured for 3 days and assayed for luciferase activity. (D) After knockdown of SSBP3 in keratinocytes, cells were further treated with 1.8 mM CaCl~2~ for 3 days. The protein expression of involucrin and loricrin were examined by western blot analysis. Actin was used as a loading control. Values are presented as mean±standard deviation of triplicate measurements (^\*^*p*\<0.01).](ad-30-432-g003){#F3}

![Immunohistochemical analysis of SSBP3 in epidermal differentiation-related skin disorders. (A) Psoriasis, (B) ichthyosis, and (C) atopic dermatitis. (A\~C) Paraffin-embedded lesional tissues were immunohistochemically stained with anti-SSBP3 (hematoxylin and DAB, ×200, scale bars=50 µm). Positive staining of SSBP3 in epidermis was quantified. PSO: psoriasis, ICH: ichthyosis, AD: atopic dermatitis, N: normal skin.](ad-30-432-g004){#F4}

###### Characteristics of enrolled subjects

![](ad-30-432-i001)

  Characteristic                        GWAS
  ------------------------------------- -------------
  No. of subjects                       100
  Chronologic age (yr)                  40.0±4.7
  Positive smoking history (%)          0
  Personal history of skin cancer (%)   0
  Skin hydration^\*^ (n=100)            58.01±16.85
   CM value ≥60 (n=52)                  73.58±4.14
   40\< CM value \<60 (n=32)            43.90±2.23
   CM value ≤40 (n=16)                  35.62±2.77

Values are presented as number only, mean±standard deviation, or %. GWAS: genome-wide association study, CM: corneometer. ^\*^Capacitance a.u. measured by Corneometer® CM 825 (Courage & Khazaka Electronic, Germany).

###### *SSBP* gene family identified in the GWAS

![](ad-30-432-i002)

  rs no. NCBI^\*^   Chr.   Position   Function   Genes     No. of samples   β        SE      *p*-value
  ----------------- ------ ---------- ---------- --------- ---------------- -------- ------- -----------
  rs12041903        1      54772434   Intron     *SSBP3*   100              −9.53    3.469   0.007156
  rs7523947         1      54766816   Intron     *SSBP3*   99               −7.952   3.022   0.009887
  rs11206323        1      54762449   Intron     *SSBP3*   99               −5.601   2.545   0.03013
  rs435070          5      80981992   Intron     *SSBP2*   97               −4.598   2.143   0.03446
  rs454578          5      80966666   Intron     *SSBP2*   98               −4.926   2.33    0.03711

GWAS: genome-wide association study, Chr.: chromosome, SE: standard error. ^\*^Single nucleotide polymorphisms on National Center for Biotechnology Information (NCBI) reference assembly.
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